Sign Out
Each 10 mL and 50 mL vial contains Rituximab (r-DNA origin) 100 mg and 500 mg, respectively.
Rituximab is a genetically engineered mouse-human chimeric monoclonal antibody representing a glycosylated immunoglobulin that contains murine light and heavy chain variable regions and human IgG1 constant region sequences. The antibody is produced by mammalian (Chinese hamster ovary) cell suspension culture and purified by affinity and ion exchange chromatographies, including specific viral inactivation and removal procedures.
Excipients/Inactive Ingredients: Sodium citrate, Polysorbate 80, Sodium chloride, Water for injection.
